Detection of stromal invasion in breast cancer: The myoepithelial markers

Advances in Anatomic Pathology

Volumn 7, Issue 2, 2000, Pages 100-109

  Yaziji, Hadi ^a   Gown, Allen M ^a   Sneige, Nour ^b  

^a PHENOPATH LABORATORIES   (United States)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

Basement membrane; Breast cancer; Calponin; Myoepithelial markers; Smooth muscle actin; Smooth muscle myosin heavy chain; Stromal invasion

Indexed keywords

BIOLOGICAL MARKER;

BREAST TUMOR; CANCER INVASION; CARCINOMA; CHEMISTRY; DIFFERENTIAL DIAGNOSIS; EPITHELIUM CELL; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; PAGET NIPPLE DISEASE; PATHOLOGY; REVIEW; SENSITIVITY AND SPECIFICITY; STROMA CELL;

BIOLOGICAL MARKERS; BREAST NEOPLASMS; CARCINOMA; CARCINOMA, INTRADUCTAL, NONINFILTRATING; DIAGNOSIS, DIFFERENTIAL; EPITHELIAL CELLS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASM INVASIVENESS; SENSITIVITY AND SPECIFICITY; STROMAL CELLS;

EID: 0034145366     PISSN: 10724109     EISSN: 15334031     Source Type: Journal    
DOI: 10.1097/00125480-200007020-00005     Document Type: Review

References (101)

1. Liberman L, Fahs MC, Dershaw DD, et al. Stereotaxic core needle biopsy of breast carcinoma: accuracy at predicting invasion. Radiology 1995;195:633-7.
2. McCombs MM, Bassett LW, Reza J, Fu YS. Imaging-guided core biopsy of the breast. Breast J 1995;1:9-16.
3. Morrow M. Clinical applications of sterotactic biopsy. Breast J 1995;1:326-9.
4. Nath ME, Robinson TM, Tobon H, et al. Automated large-core needle biopsy of surgically removed breast lesions: comparison of samples obtained with 14-, 16-, and 18-gauge needles. Radiology 1995;197:739-42.
5. Liberman L, Evans WP, Dershaw DD, et al. Radiography of microcalcifications in stereotaxic mammary core biopsy specimens. Radiology 1994;190:223-5.
6. Mainiero M, Philptts LE, Lee CH, et al. Stereotaxic core needle biopsy of breast microcalcifications: correlation of target accuracy and diagnosis with lesion size. Radiology 1996;198:665-9.
7. Liberman L, Cohen MA, Dershaw DD, Abramson AF, Hann LE, Rosen PP. Atypical ductal hyperplasia diagnosed at stereotaxic core biopsy of breast lesions: an indication of surgical biopsy. Am J Roentgenol 1995;164:1111-3.
8. Liberman L, Dershaw DD, Rosen PP, et al. Sterotaxic core biopsy of breast carcinoma: accuracy at predicting invasion. Radiology 1995;194:379-81.
9. Liberman L, Sama M, Susnik B, et al. Lobular carcinoma in situ at percutaneous breast biopsy: surgical biopsy findings. Am J Roentgenol 1999;173:291-9.
10. Yaziji H, Allred DC, Ellis IO, Schnitt S, Sneige N, Gown AM. Inter-observer variability and correlation with immunohistochemistry in distinction between invasive and non-invasive breast lesions. Mod Pathol 1999;12(1):34A.
11. Satoh Y, Oomori Y, Ishikawa K, Ono K. Configuration of myoepithelial cells in various exocrine glands of guinea pigs. Anat Embryol (Berl) 1994;189(3):227-36.
12. Nagato T, Yoshida A, Uehara Y. A scanning electron microscope study of myoepithelial cells in exocrine glands. Cell Tissue Res 1980;209:1-10.
13. Nerlich AG, Lebeau A, Hagedorn HG, Sauer U, Schleicher ED. Morphological aspects of altered basement membrane metabolism in invasive carcinomas of the breast and larynx. Anticancer Res 1998;18:3515-20.
14. Viacava P, Naccarato AG, Collecchi P, Menard S, Castronovo V, Bevilacqua G. The spectrum of 67-kD laminin receptor expression in breast carcinoma progression. J Pathol 1997;182:36-44.
15. Sternlicht MD, Kedeshian P, Shao ZM, Safarians S, Barsky SH. The human myoepithelial cells is a natural tumor suppressor. Clin Cancer Res 1997;3:1949-58.
16. Dulbecco R, Allen WR, Bologna M, Bowman M. Marker evolution during the development of the rat mammary gland: stem cells identified by markers and the role of myoepithelial cells. Cancer Res 1986;46(5):2449-56.
17. Sapino A, Macri L, Tonda L, Bussolati G. Oxytocin enhances myoepithelial cell differentiation and proliferation in the mouse mammary gland. Endocrinology 1993;133:838-42.
18. Soloff MS, Chakraborty J, Sadhukhan P, et al. Purification and characterization of mammary myoepithelial and secretory cells from the lactating rat. Endocrinology 1980;106(3):887-97.
19. Zavizion B, Politis I, Gorewit RC. Bovine mammary myoepithelial cells. 1. Isolation, culture, and characterization. J Dairy Sci 1992;75(12):3367-80.
20. Joshi K, Ellis JT, Hughes CM, Monaghan P, Neville AM. Cellular proliferation in the rat mammary gland during pregnancy and lactation. Lab Invest 1986;54:52-61.
21. Ahmed A. The myoepithelium in human breast carcinoma. J Pathol 1974;113:129-35.
22. Bussolati G, Botta G, Gugliotta P. Actin-rich (myoepithelial) cells in ductal carcinoma in situ of the breast. Virchows Arch B 1980;34:251-9.
23. Bussolati G. Actin-rich (myoepithelial) cells in lobular carcinoma in situ of the breast. Virchows Arch B 1980;32:165-76.
24. Bussolati G, Botto-Micca FB, Eusebi V, Betts CM. Myoepithelial cells in lobular carcinoma in situ of the breast: a parallel immunocytochemical and ultrastructural study. Ultrastruct Pathol 1981;2:219-30.
25. Gould VE, Jao W, Battifora H. Ultrastructural analysis in the differential diagnosis of breast tumors: the significance of myoepithelial cells, basal lamina, intracytoplasmic lumina and secretory granules. Pathol Res Pract 1980;167:45-70.
26. Gusterson BA, Warburton MJ, Mitchell D, Ellison M, Neville AM, Rudland PS. Distribution of myoepithelial cells and basement membrane proteins in the normal breast and in benign and malignant breast diseases. Cancer Res 1982;42:4763-70.
27. Visscher DW, Sarkar FH, Sakr W, Crissman J. Immunohistologic analysis of invasive phenotype in breast carcinoma. A clinicopathologic study. Pathol Res Pract 1993 Sept;189(8):867-72.
28. Wapnir IL, Southard H, Chen G, Friedman J, Boyd CD, Amenta PS. Collagen gene expression in the neomatrix of carcinoma of the breast. Invasion Metastasis 1996;16:308-16.
29. Ryan GB, Cliff WJ, Babbiani G, et al. Myofibroblasts in human granulation tissue. Hum Pathol 1974;5:55-67.
30. Ohtani H, Sasano N. Myofibroblasts and myoepithelial cells in human breast carcinoma. Virchows Arch A 1980;385:247-61.
31. Wojno KJ, Epstein JI. The utility of basal cell-specific anti-cytokeratin antibody (34 beta E12) in the diagnosis of prostate carcinoma. A review of 228 cases. Am J Surg Pathol 1995;19:251-60.
32. Rasbridge SA, Millis RR. Carcinoma in situ involving sclerosing adenosis: a mimic of invasive breast carcinoma. Histopathology 1995;27:269-73.
33. Bose S, Lesser ML, Norton L, Rosen PP. Immunophenotype of intraductal carcinoma. Arch Pathol Lab Med 1996;120:81-5.
34. Hewitt RE, Powe DG, Morell K, et al. Laminin and collagen IV subunit distribution in normal and neoplastic tissues of colorectum and breast. Br J Cancer 1997;75:221-9.
35. Takasaki T, Akiba S, Sagara Y, Yoshida H. Histological and biological characteristics of microinvasion in mammary carcinomas. Pathol Int 1998;48:800-5.
36. Prasad ML, Osborne MP, Hoda SA. Observations on the histopathologic diagnosis of microinvasive carcinoma of the breast. Anal Pathol 1998;3:209-32.
37. Raymond WA, Leong AS. Assessment of invasion in breast lesions using antibodies to basement membrane components and myoepithelial cells. Pathology 1991;23:291-7.
38. Willbrand D, Bosman FT, DeGoeij AFPM. Patterns of basement membrane deposition in benign and malignant breast tumors. Histopathology 1986;10:1231-41.
39. Isobe T, Ishioka N, Okuyama T, et al. Structural relation of two S-100 proteins in bovine brain: subunit composition of S-100a protein. Eur J Biochem 1981;115:469-74.
40. Isobe T, Okuyama T. The amino acid sequence of S-100 protein (PAP-ib protein) and its relation to the calcium-binding proteins. Eur J Biochem 1987;89:379-88.
41. Dwarakanath S, Lee AK, Delellis RA, Silverman ML, Frasca L, Wolfe HJ. S-100 protein positivity in breast carcinomas: a potential pitfall in diagnostic immunohistochemistry. Hum Pathol 1987;18:1144-8.
42. Egan MJ, Newman J, Crocker J, Collard M. Immunohistochemical localization of S100 protein in benign and malignant conditions of the breast. Arch Pathol Lab Med 1987;111:28-31.
43. Raju UB, Lee MW, Zarbo RJ, Crissman JD. Papillary neoplasia of the breast: immunohistochemically defined myoepithelial cells in the diagnosis of benign and malignant papillary breast neoplasms. Mod Pathol 1989;2:569-76.
44. Hijazi YM, Lessard JL, Weiss MA. Use of anti-actin and S100 protein antibodies in differentiating benign and malignant sclerosing breast lesions. Surg Pathol 1989;2:125-35.
45. Gillett CE, Bobrow LG, Millis RR. S100 protein in human mammary tissue-immunoreactivity in breast carcinoma, including Paget's disease of the nipple, and value as a marker of myoepithelial cells. J Pathol 1990;160:19-24.
46. Nayar R, Breland C, Befrossian U, Masood S, DeFrias D, Bedrossian CW. Immunoreactivity of ductal cells with putative myoepithelial markers: a potential pitfall in breast carcinoma. Ann Diagn Pathol 1999;3:165-73.
47. Funahashi H, Koshikawa T, Ichihara S, Ohike E, Katoh K. Different distributions of immunoreactive S100-alpha and S100-beta protein expression in human breast cancer. J Surg Oncol 1998;68:25-9.
48. Nagle RB, Bocker W, Davis JR, et al. Characterization of breast carcinomas by two monoclonal antibodies distinguishing myoepithelial from luminal epithelial cells. J Histochem Cytochem 1986;34:869-81.
49. Jarasch ED, Nagle RB, Kaufmann M, Maurer C, Bocker WJ. Differential diagnosis of benign epithelial proliferations and carcinoma of the breast using antibodies to cytokeratins. Hum Pathol 1988;19:276-89.
50. Guelstein VI, Tchypysgeva TA, Ermilova VD, Ljubimov AV. Myoepithelial and basement membrane antigens in benign and malignant human breast tumors. Int J Cancer 1993;53:269-77.
51. Gottlieb C, Raju U, Greenwald KA. Myoepithelial cells in the differential diagnosis of complex benign and malignant breast lesions: an immunohistochemical study. Mod Pathol 1990;3:135-40.
52. Heatley M, Maxwell P, Whieside C, Toner P. Cytokeratin intermediate filament expression in benign and malignant breast disease. J Clin Pathol 1995;48:26-32.
53. Joshi MG, Lee AK, Pedersen CA, Schnitt S, Camus MG, Hughes KS. The role of immunocytochemistry in the differential diagnosis of proliferative and neoplastic lesions of the breast. Mod Pathol 1996;9:57-62.
54. Gugliotta P, Sapino A, Mcr'I L, Skalli O, Gabbiani G, Bussolati G. Specific demonstration of myoepithelial cells by anti-alpha smooth muscle actin antibody. J Histochm Cytochem 1988;36:659-63.
55. Rudland PS, Leinster SJ, Winstanley J, Green B, Atckinson M, Zakhour HD. Immunocytochemical identification of cell types in benign and malignant breast diseases: variations in cell markers accompany the malignant state. J Histochem Cytochem 1993;41:543-53.
56. Bocker W, Bier B, Freytag G, et al. An immunohistochemical study of the breast using antibodies to basal and luminal keratins, alpha-smooth muscle actin, vimentin, collagen IV and laminin. Part I. Normal breast and benign proliferative lesions. Virchows Arch A 1992;421:315-22.
57. Bocker W, Bier B, Freytag G, et al. An immunohistochemical study of the breast using antibodies to basal and luminal keratins, alpha-smooth muscle actin, vimentin, collagen IV and laminin. Part II. Epitheliosis and ductal carcinoma in situ. Virchows Arch A 1992;421:323-30.
58. Gimona M, Herzog M, Vancekerekhove J, Small JV. Smooth muscle specific expression of calponin. FEBS Lett 1990;274:159-62.
59. Birukov KG, Stenapova OV, Nanaev AK, Shirinsky VP. Expression of calponin in rabbit and human aortic smooth muscle cells. Cell Tissue Res 1991;266:579-84.
60. Draeger A, Gimona M, Stuckert A, Celis JE, Small JV. Calponin: developmental insoforms and a low lolecular weight variant. FEBS Lett 1991;291:24-8.
61. Birukov KG, Frid MG, Rogers JD, et al. Synthesis and expression of smooth muscle phenotype markers in primary culture of rabbit aortic smooth muscle cells: influence of seeding density and media and relation to cell contractility. Exp Cell Res 1993;204:46-53.
62. Duband JL, Gimona M, Scatena M, Sartore S, Small JV. Calponin and SM 22 as differentiation markers of smooth muscle: spatio-temporal distribution during avian embryonic development. Differentiation 1993;55:1-11.
63. Winder SJ, Walsh MP. Calponin: thin filament-linked regulation of smooth muscle contraction. Cell Signal 1993;5:677-86.
64. Frid MG, Shekhonin BV, Koteliansky VE, Glukhova MA. Phenotypic changes of human smooth muscle cells during development: late expression of heavy caldesmon and calponin. Develop Biol 1992;153:185-93.
65. Babij P. Tissue-specific and developmentally regulated alternative splicing of a visceral isoform of smooth muscle myosin heavy chain. Nuclei Acid Res 1993;21:1467-71.
66. White S, Martin AF, Periasamy M. Identification of a novel smooth muscle myosin heavy chain cDNA: isoform diversity in the S1 head region. Am J Physiol 1993;264:1252-8.
67. Longtine JA, Pinkus GS, Fujiwara K, Corson JM. Immunohistochemical localization of smooth muscle myson in normal human tissues. J Histochemi Cytochem 1985;33:179-84.
68. Eddinger TJ, Murphy RA. Developmental changes in actin and myosin heavy chain isoform expression in smooth muscle. Arch Biochem Biophys 1991;284:232-7.
69. Frid MG, Printesva OY, Chiavegato A, et al. Myosin heavy-chain isoform composition and distribution in developing and adult human smooth muscle. J Vasc Res 1993;30:279-92.
70. Miano JM, Cserjesi P, Ligon KL, Periasamy M, Olson EN. Smooth muscle myosin heavy chain exclusively marks the smooth muscle lineage during mouse embryogenesis. Circ Res 1994;75:803-12.
71. Lazard D, Sastre X, Frid MG, Glukhova MA, Thiery JP, Koteliansky VE. Expression of smooth muscle-specific proteins in myoepithelium and stromal myofibroblasts of normal and malignant human breast tissue. Proc Natl Acad Sci USA 1993;90:999-1003.
72. Wang NP, Wan BC, Skelly M, Frid MG, Glukhova MA, Kotoliansky VE, Gown AM. Antibodies to novel myoepithelium-associated proteins distinguish benign lesions and carcinoma in situ from invasive carcinoma of the breast. Appl Immunohisochemistry 1997;5:141-51.
73. Jacobs TW, Byrne C, Colditz G, Connolly JL, Schnitt SJ. Radial scar in benign breast-biopsy specimens and the risk of breast cancer. N Engl J Med 1999;340:430-6.
74. Wallis MG, Devakumar R, Hosie KB, James KA, Bishop HM. Complex sclerosing lesions (radial scars) of the breast can be palpable. Clin Radiol 1993;48:319-20.
75. Adler DD, Helvie MA, Oberman HA, et al. Radial sclerosing lesion of the breast: mammographic features. Radiology 1990;176:737-40.
76. Franquet T, De Miguel C, Cozcolluela R, Donoso L. Spiculated lesions of the breast: mammographic-pathologic correlation. Radiographics 1993;13:841-52.
77. Spencer NJ, Evans AJ, Galea M, et al. Pathological-radiological correlations in benign lesions excised during a breast screening programme. Clin Radiol 1994;49:853-6.
78. Burnett SJ, Ng YY, Perry NM, Gilmore OJ, Allum WH, Carpenter R, Wells CA. Benign biopsies in the prevalent round of breast screening: a review of 137 cases. Clin Radiol 1995;50:254-8.
79. Frouge C, Tristant H, Guinebretiere JM, et al. Mammographic lesions suggestive of radial scars: microscopic findings in 40 cases. Radiology 1995;195:623-5.
80. Bonzanini M, Gilioli E, Brancato B, Pellegrini M, Mauri MF, Dalla Palma P. Cytologic features of 22 radial scar/complex sclerosing lesions of the breast, three of which are associated with carcinoma: clinical, mammographic, and histologic correlation. Diagn Cytopathol 1997;17:353-62.
81. Alleva DQ, Smetherman DH, Farr GH Jr, Cederbom GJ. Radial scar of the breast: radiologic-pathologic correlation in 22 cases. Radiographics 1999;S27-35.
82. Markopoulos C, Kakisis J, Koufopoulos K, et al. Radial scar of the breast. Gynecol Oncol 1999;20:147-9.
83. Rickert RR, Kalisher L, Hutter RVP. Indurate mastoopathy: a benign sclerosing lesion of breast with elastosis which may simulate carcinoma. Cancer 1981;47:561-71.
84. Anderson JA, Carter D, Linell F. A symposium on sclerosing duct lesions of the breast. Pathol Annual 1986;Part 2:145-79.
85. Sloane JP, Mayers MM. Carcinoma and atypical hyperplasia in radial scars and complex sclerosing lesions: importance of lesion size and patient age. Histopathology 1993;23:225-31.
86. Fechner RE. Lobular carcinoma in situ in sclerosing adenosis. A potential source of confusion with invasive carcinoma. Am J Surg Pathol 1981;5:233-9.
87. Eusebi V, Collina G, Bussolati G. Carcinoma in situ in sclerosing adenosis of the breast: an immunocytochemical study. Semin Diagn Pathol 1989;6:146-52.
88. Oberman HA, Markey BA. Noninvasive carcinoma of the breast presenting in adenosis. Mod Pathol 1991;4:31-5.
89. Prasad ML, Osborne MP, Hoda SA. Observations on the histopathologic diagnosis of microinvasive carcinoma of the breast. Anat Pathol 1998;3:209-32.
90. Hoda SA, Prasad ML, Moore A, Hoda RS, Giri D. Microinvasive carcinoma of the breast: can it be diagnosed reliably and is it clinically significant? Histopathology 1999;35:468-70.
91. Ellis IO, Lee AHS, Elston CW, Pinder SE. Microinvasive carcinoma of the breast: diagnostic criteria and clinical relevance. Histopathology 1999;35:470-2.
92. Page DL, Dixon JM, Anderson TJ, Lee D, Stewart HJ. Invasive cribriform carcinoma of the breast. Histopathology 1983;7:525-36.
93. Venable JG, Schwartz AM, Silverberg SG. Infiltrating cribriform carcinoma of the breast: a distinctive clinicopathologic entity. Hum Pathol 1990;21:333-8.
94. Orenstein JM, Dardick I, van Nostrand AWP. Ultrastructural similarities of adenoid cystic carcinoma and pleomorphic adenoma. Histopathology 1985;9:623-38.
95. Ro JY, Silva EG, Gallager HS. Adenoid cystic carcinoma of the breast. Hum Pathol 1987;18:1276-81.
96. Rosen PP. Adenoid cystic carcinoma of the breast. A morphologically heterogeneous neoplasm. Pathol Ann 1989;24:237-54.
97. Clement PB, Young RH, Azzopardi JG. Collagenous spherulosis of the breast. Am J Surg Pathol 1987;11:411-7.
98. Carter D. Intraductal papillary tumors of the breast. A study of 76 cases. Cancer 1977;39:1689-92.
99. Perzin KH, lattes R. Papillary adenoma of the nipple (florid papillomatosis, adenoma, adenomatosis). A clinicopathologic study. Cancer 1972;29:996-1009.
100. Rosen PP. Syringomatous adenoma of the nipple. Am J Surg Pathol 1983;7:739-45.
101. Liberman L, Vuolo M, Dershaw DD, et al. Epithelial displacement after stereotactic 11-gauge directional vacuum-assisted breast biopsy. Am J Roengenol 1999;172:677-81.